Organigram Global Inc. (OGI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $1.43. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of OGI = $7.93 (+454.5% from the current price, the stock appears undervalued).
Valuation: OGI trades at a trailing Price-to-Earnings (P/E) of 14.3 (S&P 500 average ~25).
Financials: revenue is $186M, +8.6%/yr average growth. Net income is $18M (loss), growing at -455.2%/yr. Net profit margin is -9.6% (negative). Gross margin is 3.7% (-18 pp trend).
Balance sheet: total debt is $9M against $349M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 2.26 (strong liquidity). Debt-to-assets is 1.6%. Total assets: $562M.
Analyst outlook: 2 / 5 analysts rate OGI as buy (40%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 93/100 (Pass), Growth 40/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 8/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).
